NCT03761797 A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT03760822 Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03758430 A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes Status COMPLETED Phase N/A
NCT03752177 A Study of LY3415244 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03750643 A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03745430 RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT03743285 A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D) Status COMPLETED Phase NA
NCT03742973 A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA Status TERMINATED Phase PHASE2
NCT03740919 A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT03740529 A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL Status COMPLETED Phase PHASE1/PHASE2
NCT03736785 A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT03736772 A Study of LY3090106 in Japanese and Caucasian Healthy Participants Status COMPLETED Phase PHASE1
NCT03736486 Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the Latino Community Status COMPLETED Phase N/A
NCT03735446 Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial Status TERMINATED Phase PHASE1
NCT03733301 A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03730662 A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk Status COMPLETED Phase PHASE3